Diversified’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Diversified’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,863	Closed	-$9.8K	–	149
2023 Q2	$9.8K	Hold	32,863	–	–	﹤0.01%	144
2023 Q1	$14.2K	Sell	32,863 -50,000	-60%	-$38.4K	0.01%	145
2022 Q4	$97.8K	Hold	82,863	–	–	0.04%	155
2022 Q3	$192K	Buy	+82,863	New	+$217K	0.1%	120

Diversified's GRNA Position: Q3 2023 in Review

Diversified sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 32,863 shares — an estimated $9.8K sold.

Diversified first reported a position in GRNA in Q3 2022 and held it in 4 quarters. The position peaked at $192K in Q3 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Diversified reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Diversified sold 32,863 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $9.8K.
Diversified first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 4 quarters.
Diversified's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $192K in Q3 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Diversified's 13F filing for Q3 2023, filed 2 Nov 2023.